The drug used for COVID-19 patients at an eastern Ontario hospital is part of the investigation into Dr. Brian Nadler’s murder, UKTN News has learned.
Nadler, a doctor at Hawkesbury and District General Hospital, has been charged with one count of first degree murder in the death of patient Albert Poidinger, 89.
The Ontario Provincial Police (OPP) said it was awaiting the results of post-mortem investigations on several other people who recently died in hospital.
An Ontario Provincial Police spokesperson called the deaths “potentially suspicious.”
The OPP did not confirm whether Poidinger was one of Nadler’s patients or whether he had any connections to other patients.
However, sources close to the investigation confirmed a report in the Ottawa Citizen that police are examining at least five COVID-19 patients who died in hospital between March 17 and March 25. The sources spoke on condition of anonymity because they were not authorized. speak publicly.
Nadler, 35, was arrested in hospital last week. Those same sources told UKTN News that police were responding to a call that day from a hospital whistleblower.
He appeared in remote court on Friday.
Nadler’s attorney, Alan Brass, claims his client maintains his innocence.
On Thursday, before Nadler’s arrest, the hospital reported a major outbreak of COVID-19, the second in just a week, involving 16 patients and five staff who tested positive, and five deaths.
The death toll contrasts with the number of deaths from COVID-19 reported by the United Counties of Prescott Russell – an area of the Eastern Ontario Health Unit – which reported a single death in January and two in February.
The College of Physicians and Surgeons is also investigating Nadler and has suspended his license.
Nadler had just started working at the hospital in 2020 and was under a restricted license, which meant he remained under the supervision of another doctor for a year until February 3, 2021, UKTN News has learned.
Under the terms of the restriction, the supervising physician was to inform the college “of any concerns regarding the knowledge, skills, judgment or attitude of Dr. Nadler”.
The college says it will not provide details of the licensing restriction, adding in a statement to UKTN: “There are a number of circumstances in which the College may require a clinical supervisor in other jurisdictions, and whether the physician has exercised continuously or has not exercised for a long time. “